UPN2357_250_S203_L006_R2_001.fastq.gz

syn25955228

Created By Elliot Stieglitz estieglitz

sex: nan
eTag: f044128f-08ad-4b5e-979b-18a32b24b39a
assay: next generation targeted sequencing
organ: nan
tissue: nan
runType: pairedEnd
species: Homo sapiens
studyId: syn51133946
Filename: Newborn screening cards/Targeted Sequencing/UPN2357_250_S203_L006_R2_001.fastq.gz
cellType: nan
comments: nan
dataType: genomicVariants
entityId: syn25955228
platform: Illumina NovaSeq 6000
readPair: 2
diagnosis: nan
readDepth: nan
studyName: DHART SPORE Project 3 Phase 1 - A High Content Clinical Trial of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML)
tumorType: nan
fileFormat: fastq
initiative: Developmental and HyperActive Ras Tumor Specialized Programs of Research Excellence
isCellLine: None
isStranded: nan
readLength: 150
specimenID: nan
dataSubtype: raw
libraryPrep: nan
nf1Genotype: nan
nf2Genotype: nan
individualID: nan
resourceType: experimentalData
fundingAgency: NIH-NCI
genePerturbed: nan
isPrimaryCell: nan
timePointUnit: nan
modelSystemName: nan
readStrandOrigin: nan
nucleicAcidSource: bulk cell
dissociationMethod: nan
readPairOrientation: nan
genePerturbationType: nan
progressReportNumber: nan
experimentalCondition: nan
experimentalTimepoint: nan
libraryPreparationMethod: nan
specimenPreparationMethod: nan
genePerturbationTechnology: nan

UPN2357_250_S203_L006_R2_001.fastq.gz page is loading…